|
|
 |
|
|
|
|
News
ANR selects Hemarina’s HEMO2Perf® project
Morlaix, Brittany, Novembre 7th, 2011 - The French National Research Agency is to fund the HEMO2Perf® project, demonstrating once again the scientific and therapeutic interest in the oxygen... More + |
American Journal of Transplantation
HEMARINA announces that a study on the use of HEMO2Life® has just been published in the American Journal of Transplantation, the leading journal in the field of transplantationThis paper... More + |
The ESOT Young Investigator Award
Morlaix, Brittany, September 15th, 2011 - HEMARINA, a young French biotechnology company that is developing breakthrough innovations from oxygen carriers of marine origin announces the distinction of... More + |
|
|
|
Corporate
|
Technology & Products
|
Intellectual Property
|
Investors |
News & Media
|
 |
>> Company Overview
>> Managment Team
>> Board of Directors
>> Scientific and Ethics Board
>> Hemarina Label and Public Funding
|
|
>> Organ Preservation
>> Wound Healing
>> Hemoglobin Oxygen-Carrier
>> Cell Culture and Bioproduction
>> Other Perspective
|
|
>> Portfolio
>> Literature References
|
|
|
|
>> News
>> Hemarina Awards
>> Press Releases
>> Video Releases
>> 2012
|
|
|
